baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ELI LILLY/ US5324571083 /

2/2/2024 4:00:28 PM	Chg. +7.50	Volume	Bid10:44:27 AM	Ask10:44:29 AM	Market Capitalization	Dividend Y.	P/E Ratio
613.00EUR	+1.24%	0 Turnover: 0.00	709.00Bid Size: 30	712.60Ask Size: 30	674.43 bill.EUR	-	-

GlobeNewswire 5/16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 5/16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 5/16 HEPHAISTOS secures €10.3 M to reach the clinical stage

GlobeNewswire 5/15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 5/13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 5/9 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 5/9 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...

GlobeNewswire 5/9 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 5/8 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 5/8 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 5/8 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire 5/8 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...

GlobeNewswire 5/8 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

GlobeNewswire 5/3 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...

GlobeNewswire 5/1 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors

GlobeNewswire 4/30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

TeleTrader 4/30 Eli Lilly's Q1 revenue surges 26% to $8.8B

GlobeNewswire 4/30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

GlobeNewswire 4/29 BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results

GlobeNewswire 4/29 BeyondSpring Files 2023 Annual Report on Form 20-F

GlobeNewswire 4/29 Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...

GlobeNewswire 4/26 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...

GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 4/23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 4/22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

ELI LILLY/ US5324571083 /

If you wish to receive reply to your feedback, please provide your email address.